X-108580548-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_033380.3(COL4A5):c.796C>T(p.Arg266*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_033380.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change creates a premature translational stop signal (p.Arg266*) in the COL4A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL4A5 are known to be pathogenic (PMID: 9195222, 10752524, 14514738, 24854265, 26809805). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Alport syndrome (PMID: 15780079, 17396119, 29854973). ClinVar contains an entry for this variant (Variation ID: 24325). For these reasons, this variant has been classified as Pathogenic. -
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 15780079, 25525159, 15954103, 17396119) -
X-linked Alport syndrome Pathogenic:3
- -
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
The COL4A5 c.796C>T; p.Arg266Ter variant (rs104886071) is reported in the literature in several heterozygous and hemizygous individuals with symptoms of Alport syndrome (Gillion 2018, Kim 2023, Mastrangelo 2020, Nagel 2005, Rao 2019, Slajpah 2007, Wang 2005). This variant is reported as pathogenic in ClinVar (Variation ID: 24325). This variant is also absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Gillion V et al. Genotype and Outcome After Kidney Transplantation in Alport Syndrome. Kidney Int Rep. 2018 Feb 2;3(3):652-660. PMID: 29854973. Kim JH et al. Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea. Sci Rep. 2023 Apr 26;13(1):6827. PMID: 37100867. Mastrangelo A et al. X-Linked Alport Syndrome in Women: Genotype and Clinical Course in 24 Cases. Front Med (Lausanne). 2020 Nov 23;7:580376. PMID: 33330536. Nagel M et al. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat. 2005 Jul;26(1):60. PMID: 15954103. Rao J et al. Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. Clin Genet. 2019 Nov;96(5):402-410. PMID: 31328266. Slajpah M et al. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria. Kidney Int. 2007 Jun;71(12):1287-95. PMID: 17396119. Wang F et al. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int. 2005 Apr;67(4):1268-74. PMID: 15780079. -
Alport syndrome Pathogenic:1
This patient is heterozygous for a known pathogenic variant, c.796C>T, in the COL4A5 gene. This variant (dbSNP: rs104886071) creates a premature stop codon (p.Arg266*) and may result in a null allele due to nonsense-mediated mRNA decay. This variant has been previously reported in the COL4A5 Alport database (http://www.arup.utah.edu/database/ALPORT/ALPORT_welcome.php) and is considered to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at